These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 26306783

  • 1. MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells.
    Cortés C, Kozma SC, Tauler A, Ambrosio S.
    Cell Oncol (Dordr); 2015 Oct; 38(5):341-52. PubMed ID: 26306783
    [Abstract] [Full Text] [Related]

  • 2. Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas.
    Torres J, Regan PL, Edo R, Leonhardt P, Jeng EI, Rappaport EF, Ikegaki N, Tang XX.
    Int J Oncol; 2010 Oct; 37(4):983-91. PubMed ID: 20811720
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.
    Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM, Chung DH.
    Biochem Biophys Res Commun; 2006 Dec 08; 351(1):192-7. PubMed ID: 17055458
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D, Bannert S, Henrich KO, Schröder C, Bender S, Oakes CC, Lindner S, Schulte JH, Duffy D, Schwarzl T, Saadati M, Ehemann V, Benner A, Pfister S, Fischer M, Westermann F.
    Hum Mol Genet; 2014 Dec 20; 23(25):6826-37. PubMed ID: 25104850
    [Abstract] [Full Text] [Related]

  • 8. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M.
    Genome Biol; 2008 Oct 13; 9(10):R150. PubMed ID: 18851746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
    Casalà C, Gil-Guiñón E, Ordóñez JL, Miguel-Queralt S, Rodríguez E, Galván P, Lavarino C, Munell F, de Alava E, Mora J, de Torres C.
    Carcinogenesis; 2013 Feb 13; 34(2):268-76. PubMed ID: 23108190
    [Abstract] [Full Text] [Related]

  • 13. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
    Petroni M, Veschi V, Prodosmo A, Rinaldo C, Massimi I, Carbonari M, Dominici C, McDowell HP, Rinaldi C, Screpanti I, Frati L, Bartolazzi A, Gulino A, Soddu S, Giannini G.
    Mol Cancer Res; 2011 Jan 13; 9(1):67-77. PubMed ID: 21173028
    [Abstract] [Full Text] [Related]

  • 14. GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling.
    Duffy DJ, Krstic A, Schwarzl T, Higgins DG, Kolch W.
    Mol Cancer Ther; 2014 Feb 13; 13(2):454-67. PubMed ID: 24282277
    [Abstract] [Full Text] [Related]

  • 15. MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma.
    Lau DT, Flemming CL, Gherardi S, Perini G, Oberthuer A, Fischer M, Juraeva D, Brors B, Xue C, Norris MD, Marshall GM, Haber M, Fletcher JI, Ashton LJ.
    Oncotarget; 2015 Jun 20; 6(17):15510-23. PubMed ID: 25860940
    [Abstract] [Full Text] [Related]

  • 16. Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth.
    Li Y, Zhang B, Zhang H, Zhu X, Feng D, Zhang D, Zhuo B, Li L, Zheng J.
    J Cancer Res Clin Oncol; 2013 Jun 20; 139(6):933-41. PubMed ID: 23443256
    [Abstract] [Full Text] [Related]

  • 17. Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas.
    Kaneko Y, Suenaga Y, Islam SM, Matsumoto D, Nakamura Y, Ohira M, Yokoi S, Nakagawara A.
    Cancer Sci; 2015 Jul 20; 106(7):840-7. PubMed ID: 25880909
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A, Im SA, Kim DK, Song SH, Kim HJ, Lee KH, Kim TY, Han SW, Oh DY, Kim TY, O'Connor MJ, Bang YJ.
    Breast Cancer Res; 2015 Mar 07; 17():33. PubMed ID: 25888415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.